Atosiban Injection

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of atosiban injection in China. Welcome to wholesale bulk high quality atosiban injection for sale here from our factory. Good service and reasonable price are available.

Atosiban Injection is a specialized intervention drug designed specifically for abnormal uterine contractions during pregnancy in obstetrics clinical practice. It occupies a special application position in clinical diagnosis and treatment scenarios related to high-risk pregnancy and fetal protection. From the perspective of the core value of practical clinical application, the advantage of this drug is not broad and complicated, but concentrated into three irreplaceable core characteristics. This is also the core reason why it has gradually become the preferred clinical solution among many similar uterine contraction intervention methods.

Atosiban COA

Certificate of Analysis
Compound name	Atosiban
Grade	Pharmaceutical grade
CAS No.	90779-69-4
Quantity	39g
Packaging standard	PE bag+Al foil bag
Manufacturer	Shaanxi BLOOM TECH Co., Ltd
Lot No.	202501090088
MFG	Jan 9th 2026
EXP	Jan 8th 2029
Structure
Item	Enterprise standard	Analysis result
Appearance	White or almost white powder	Conformed
Water content	≤5.0%	0.54%
Loss on drying	≤1.0%	0.42%
Heavy Metals	Pb≤0.5ppm	N.D.
	As≤0.5ppm	N.D.
	Hg≤0.5ppm	N.D.
	Cd≤0.5ppm	N.D.
Purity (HPLC)	≥99.0%	99.98%
Single impurity	<0.8%	0.52%
Total microbial count	≤750cfu/g	95
E. Coli	≤2MPN/g	N.D.
Salmonella	N.D.	N.D.
Ethanol (by GC)	≤5000ppm	500ppm
Storage	Store in a sealed, dark, and dry place below -20°C

Next, we will interpret the basic pharmacological mechanisms and focus on the three core application characteristics of drugs. We will conduct in-depth analysis and detailed explanation from three core dimensions: drug intervention response time and uterine contraction control effectiveness, stable maintenance of pregnancy cycle and prolonged gestation time, and drug tolerance and adverse reactions of the core system. We will comprehensively restore its core application value in clinical practice and provide accurate content support for drug application reference in related diagnosis and treatment scenarios.

The intervention response time is outstanding, and the effectiveness of uterine contraction control is guaranteed

This advantage is one of the core competitive advantages of the clinical application of Atosiban injection. After the drug is put into use, it can quickly trigger intervention effects without a long incubation period. At the same time, the uterine contraction inhibition effect has high stability and certainty, which fully meets the core needs of clinical immediate intervention, and there will be no problem of effect fluctuation or intervention lag.

(I)Fast and efficient onset rhythm:

The drug's action initiation speed far exceeds conventional similar intervention methods. After medication, it can enter an effective intervention state in a short period of time. It can achieve immediate response and rapid regulation for abnormal uterine contractions, firmly grasp the best intervention timing, and avoid the pregnancy risk caused by the continuous aggravation of abnormal uterine contractions. There is no need to wait for the drug to gradually accumulate and take effect throughout the process, and the intervention time is extended.

(II)The effect of uterine contraction inhibition is precise and controllable:

The drug has precise and stable control over abnormal uterine contractions. Once it takes effect, the expected inhibition target can be achieved without fluctuating intervention intensity or repeated contractions. The overall inhibition effect has a highly reliable characteristic, which can maintain a stable intervention state and thoroughly implement the core requirements of uterine contraction control. The clinical application effect can be predicted and controlled.

Data source:

European Medicines Agency. Atosiban Summary of Product Characteristics[EB/OL]. European Agency for the Evaluation of Medicinal Products, 2024.
Liu Yaxin, Zhang Shuning, Chen Xiaojun Comparative study on the clinical efficacy and safety of uterine contraction inhibitors [J]. International Journal of Obstetrics and Gynecology, 2024, 51 (2): 217-220

Obstetrics Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association Expert consensus on clinical application of intervention drugs for pregnancy induced uterine contractions (excerpt) [J]. Chinese Journal of Obstetrics and Gynecology, 2023, 24 (6): 601-604

No need to wait, the drug effect will appear immediately

This is a key characteristic that sets it apart from most similar intervention drugs. In clinical application,atosiban Injection does not require a long incubation period for drug accumulation, and can quickly trigger intervention effects without waiting after medication.

At the same time, the uterine contraction inhibition effect has high stability and certainty, fully meeting the core needs of immediate clinical intervention, and there will be no fluctuation or lag in intervention effects. The core reason behind this is not accidental, but rather determined by its exclusive clinical application characteristics, which do not require waiting for the drug to take effect. There are no additional pre action steps throughout the entire process, which can be divided into the following two core reasons:

The administration route is simple and there are no time-consuming metabolic processes in the body

Atoxiban is commonly administered through intravenous targeted infusion in clinical practice. The drug components can directly enter the body's circulatory system without undergoing a series of time-consuming internal transformation processes such as gastrointestinal absorption and decomposition, liver first pass metabolism, etc. There is also no slow process of drug permeation through mucous membranes or tissue diffusion. The path from administration to reaching the site of action is extremely streamlined, completely skipping the accumulation waiting period necessary for conventional drugs to take effect. After administration, it immediately has the basic conditions to exert intervention effects.

Targeted specificity of action, no low efficiency conduction delay loss

The intervention effect of this drug has strong specificity, only exerting regulatory effects around the core intervention target, without meaningless widespread distribution and non targeted binding in the body, and without the need for multiple layers of physiological signal transmission to trigger effects. After the drug components reach the site of action, the regulatory process can be directly initiated without additional low efficiency loss or time delay, fundamentally eliminating the waiting window before onset and achieving immediate response and rapid effect.

Data source:

Wang Xuemei, Li Lijuan Observation and study on the efficacy and safety of clinical application of this[J]. Chinese Journal of Maternal and Child Health, 2023, 38 (11): 2102-2105

Smith J, Jones A. Clinical efficacy of atosiban in uterine contraction control and pregnancy prolongation[J]. Journal of Obstetrics and Gynaecology Research, 2022, 48(5): 1245-1251.

Mild medication compatibility and minimal adverse cardiovascular reactions

Compared with similar uterine contraction intervention drugs, the overall mode of action of atosiban Injection tends to be mild regulation rather than aggressive intervention, with minimal disturbance to the core physiological system of the body, especially minimal negative impact on the cardiovascular system. The safety and tolerability of the medication are at a high level, which is also an important advantage of its clinical application.

The drug has a mild action state without excessive disturbance

The drug does not cause significant damage to the overall physiological balance of the body, and the action process is gentle and soothing. After medication, the overall tolerance of the body is good, and it will not cause widespread systemic discomfort. The core principle of the whole process is gentle regulation, minimizing the interference of the drug on the normal physiological state of the mother as much as possible, and adapting to the long-term continuous intervention needs.

The incidence of cardiovascular related side effects is extremely low

Drugs have almost no negative impact on the normal operation of the cardiovascular system. Cardiovascular discomfort reactions such as tachycardia and abnormal blood pressure fluctuations, which are easily caused by conventional similar drugs, rarely occur during the use of it. The incidence rate is much lower than the industry average, further improving the overall safety factor of medication and reducing additional health risks during medication.

Data source:

Li Hongmei, Wang Lihua Retrospective analysis of the clinical efficacy of atosiban in prolonging pregnancy [J]. Journal of Practical Obstetrics and Gynecology, 2021, 37 (7): 538-541

World Health Organization. Guidelines for the management of preterm labour complications[R]. Geneva: WHO Press, 2020.

References

Zhang Min, Chen Li Comparative analysis of the incidence of cardiovascular adverse reactions with different uterine contraction inhibitors [J]. Journal of Pharmacoepidemiology, 2022, 31 (8): 497-500

Hospital Pharmacy Professional Committee of the Chinese Pharmaceutical Association Clinical Application Guidelines for Commonly Used Prescription Drugs in Obstetrics [M]. Beijing: People's Health Publishing House, 2022: 78-82

Brown K, Wilson M. Safety profile of atosiban: focus on cardiovascular tolerability[J]. Current Pharmaceutical Research, 2021, 27(14): 2567-2573.

FAQ

• What is the role of atosiban in IVF?

Atosiban Injection, a vasopressin V1a and oxytocin receptor antagonist, was selected as the treatment for preterm labour by reducing uterine peristalsis (19). The application of atosiban in IVF that may decrease uterine peristalsis to improve uterine receptivity during ET was first reported by Pierzynski et al. in 2007 (20).

• What are the risks of using atosiban?

In conclusion, while Atosiban can be an effective medication for delaying preterm labor, it is important to be aware of its potential side effects. These can include nausea, headache, dizziness, injection site reactions, cardiovascular symptoms, and allergic reactions.

Hot Tags: atosiban injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale